Schedule 13D ownership disclosure

SPECTRUM PHARMACEUTICALS INC

Security class unavailable · CUSIP: 84763A108

Event date: 2022-01-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
15,332,331
Percent of class
8.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-22-004782
Form type
SC 13D
Filer
Hanmi Pharmaceutical Co., Ltd.
CIK
CIK 1904921
Filed
Feb 01, 2022
Reporting period
Jan 24, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub